Literature DB >> 32767809

Magnetic resonance imaging after ligation of the intersphincteric fistula tract for high perianal fistulas in Crohn's disease: a retrospective cohort study.

E M Meima-van Praag1, K L van Rijn2, M A Monraats2, C J Buskens1, J Stoker2.   

Abstract

AIM: Ligation of the intersphincteric fistula tract (LIFT) is increasingly being used for surgical closure of high perianal fistulas in Crohn's disease. Currently, data on postoperative MRI findings are scarce, although they are considered important for assessing healing and recurrence. Our aim, therefore, was to evaluate fistula characteristics on MRI and their relationship with clinical outcomes after LIFT.
METHOD: Consecutive Crohn's patients treated with LIFT between 2007 and 2018 who underwent baseline and follow-up MRI were retrospectively included. MRIs were scored by two radiologists according to characteristics based on the original and modified Van Assche indices. MRI findings, with emphasis on fibrosis, and the relationship with clinical healing, re-interventions and recurrences are described.
RESULTS: Twelve patients were included [four men, median age 34 (interquartile range 28-39) years]. Follow-up MRI was performed at a median of 5.5 months (interquartile range 2.5-6.0) after LIFT. At baseline, all patients showed a tract with predominantly granulation tissue, which changed to predominantly fibrotic in seven (in three of whom it was completely fibrotic). All patients with a (predominantly) fibrotic tract had clinical closure and no re-interventions or recurrences during long-term follow-up. In contrast, of the five patients with persisting granulation tissue, two reached clinical healing, two needed re-intervention and one had a recurrence.
CONCLUSION: Markedly decreased fistula activity can be observed on MRI after LIFT. The majority of patients develop a predominantly fibrotic tract relatively soon after LIFT without clinical recurrence, suggesting a highly effective therapy. Unfavourable clinical outcomes were only present in patients with persisting granulation tissue, indicating the potential prognostic value of MRI.
© 2020 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Perianal fistula; ligation of intersphincteric tract; magnetic resonance imaging; perianal Crohn’s disease

Year:  2020        PMID: 32767809      PMCID: PMC7891352          DOI: 10.1111/codi.15296

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  20 in total

1.  The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Authors:  David A Schwartz; Edward V Loftus; William J Tremaine; Remo Panaccione; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

2.  Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.

Authors:  Siew C Ng; Sophie Plamondon; Arun Gupta; David Burling; Anna Swatton; Carolynne J Vaizey; Michael A Kamm
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

3.  A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease.

Authors:  Krisztina B Gecse; Willem Bemelman; Michael A Kamm; Jaap Stoker; Reena Khanna; Siew C Ng; Julián Panés; Gert van Assche; Zhanju Liu; Ailsa Hart; Barrett G Levesque; Geert D'Haens
Journal:  Gut       Date:  2014-06-20       Impact factor: 23.059

4.  ECCO-ESCP Consensus on Surgery for Crohn's Disease.

Authors:  Willem A Bemelman; Janindra Warusavitarne; Gianluca M Sampietro; Zuzana Serclova; Oded Zmora; Gaetano Luglio; Anthony de Buck van Overstraeten; John P Burke; Christianne J Buskens; Francesco Colombo; Jorge Amil Dias; Rami Eliakim; Tomás Elosua; I Ethem Gecim; Sanja Kolacek; Jaroslaw Kierkus; Kaija-Leena Kolho; Jérémie H Lefevre; Monica Millan; Yves Panis; Thomas Pinkney; Richard K Russell; Chaya Shwaartz; Carolynne Vaizey; Nuha Yassin; André D'Hoore
Journal:  J Crohns Colitis       Date:  2018-01-05       Impact factor: 9.071

5.  ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.

Authors:  Christian Maaser; Andreas Sturm; Stephan R Vavricka; Torsten Kucharzik; Gionata Fiorino; Vito Annese; Emma Calabrese; Daniel C Baumgart; Dominik Bettenworth; Paula Borralho Nunes; Johan Burisch; Fabiana Castiglione; Rami Eliakim; Pierre Ellul; Yago González-Lama; Hannah Gordon; Steve Halligan; Konstantinos Katsanos; Uri Kopylov; Paulo G Kotze; Eduards Krustinš; Andrea Laghi; Jimmy K Limdi; Florian Rieder; Jordi Rimola; Stuart A Taylor; Damian Tolan; Patrick van Rheenen; Bram Verstockt; Jaap Stoker
Journal:  J Crohns Colitis       Date:  2019-02-01       Impact factor: 9.071

6.  Anal fistula plug versus surgeon's preference for surgery for trans-sphincteric anal fistula: the FIAT RCT.

Authors:  David G Jayne; John Scholefield; Damian Tolan; Richard Gray; Richard Edlin; Claire T Hulme; Andrew J Sutton; Kelly Handley; Catherine A Hewitt; Manjinder Kaur; Laura Magill
Journal:  Health Technol Assess       Date:  2019-05       Impact factor: 4.014

7.  Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.

Authors:  Julián Panés; Damián García-Olmo; Gert Van Assche; Jean Frederic Colombel; Walter Reinisch; Daniel C Baumgart; Axel Dignass; Maria Nachury; Marc Ferrante; Lili Kazemi-Shirazi; Jean C Grimaud; Fernando de la Portilla; Eran Goldin; Marie Paule Richard; Mary Carmen Diez; Ignacio Tagarro; Anne Leselbaum; Silvio Danese
Journal:  Gastroenterology       Date:  2017-12-24       Impact factor: 22.682

8.  ACR Appropriateness Criteria Crohn Disease.

Authors:  David H Kim; Laura R Carucci; Mark E Baker; Brooks D Cash; Jonathan R Dillman; Barry W Feig; Kathryn J Fowler; Kenneth L Gage; Richard B Noto; Martin P Smith; Vahid Yaghmai; Judy Yee; Tasneem Lalani
Journal:  J Am Coll Radiol       Date:  2015-10       Impact factor: 5.532

9.  Ligation of the Intersphincteric Fistula Tract and Endorectal Advancement Flap for High Perianal Fistulas in Crohn's Disease: A Retrospective Cohort Study.

Authors:  Elise M van Praag; Merel E Stellingwerf; Jarmila D W van der Bilt; Wilhelmus A Bemelman; Krisztina B Gecse; Christianne J Buskens
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

10.  Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas.

Authors:  M E Stellingwerf; E M van Praag; P J Tozer; W A Bemelman; C J Buskens
Journal:  BJS Open       Date:  2019-01-21
View more
  4 in total

Review 1.  Comparison between recent sphincter-sparing procedures for complex anal fistulas-ligation of intersphincteric tract vs transanal opening of intersphincteric space.

Authors:  Pankaj Garg
Journal:  World J Gastrointest Surg       Date:  2022-05-27

Review 2.  Surgical management of Crohn's disease: a state of the art review.

Authors:  Elise Maria Meima-van Praag; Christianne Johanna Buskens; Roel Hompes; Wilhelmus Adrianus Bemelman
Journal:  Int J Colorectal Dis       Date:  2021-02-02       Impact factor: 2.571

3.  A Novel MRI and Clinical-Based Scoring System to Assess Post-Surgery Healing and to Predict Long-Term Healing in Cryptoglandular Anal Fistulas.

Authors:  Pankaj Garg; Vipul D Yagnik; Sushil Dawka; Baljit Kaur; Geetha R Menon
Journal:  Clin Exp Gastroenterol       Date:  2022-02-17

4.  Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.

Authors:  Kyra L van Rijn; Elise M Meima-van Praag; Patrick M Bossuyt; Geert R D'Haens; Krisztina B Gecse; Karin Horsthuis; Harmanna J Snijder; Jeroen A W Tielbeek; Christianne J Buskens; Jaap Stoker
Journal:  J Crohns Colitis       Date:  2022-06-24       Impact factor: 10.020

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.